Page last updated: 2024-11-07

1-(4-bromoacetamidobenzyl)edta

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-(4-bromoacetamidobenzyl)EDTA: bifunctional chelating agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(S)-1-(4-bromoacetamidobenzyl)EDTA : A tetracarboxylic acid consisting of ethylenediaminetetraacetic acid having a 4-bromoacetamidobenzyl group at the C1-position and (S)-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID133744
CHEBI ID59055
SCHEMBL ID2538468
MeSH IDM0124315

Synonyms (20)

Synonym
CHEBI:59055
1-(para-bromoacetamidobenzyl)edta
(s)-1-(4-bromoacetamidobenzyl)edta
2-[[(2s)-1-[bis(carboxymethyl)amino]-3-[4-[(2-bromoacetyl)amino]phenyl] propan-2-yl]-(carboxymethyl)amino]acetic acid
n-4-(2,3-bis(bis(carboxymethyl)amino)propyl)phenyl bromoacetamide
81677-64-7
pbab-edta
glycine, n,n'-(1-((4-((bromoacetyl)amino)phenyl)methyl)-1,2-ethanediyl)bis(n-(carboxymethyl)-, (s)-
1-(4-bromoacetamidobenzyl)edta
2,2',2'',2'''-{[(2s)-3-{4-[(bromoacetyl)amino]phenyl}propane-1,2-diyl]dinitrilo}tetraacetic acid
2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-[(2-bromoacetyl)amino]phenyl]propyl]-(carboxymethyl)amino]acetic acid
SCHEMBL2538468
(s)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetic acid
(s)-1-(p-bromoacetamido-benzyl)ethylene diamine tetraacetic acid
p-bromoacetamido benzyl-edta
Q27126420
n,n'-[(1s)-1-[[4-[(bromoacetyl)amino]phenyl]methyl]-1,2-ethanediyl]bis[n-(carboxymethyl)-glycine
2,2',2'',2'''-({3-[4-(2-bromoacetamido)phenyl]propane-1,2-diyl}dinitrilo)tetraacetic acid
DTXSID001002122
(s)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetic acid (~80%)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chelatorA ligand with two or more separate binding sites that can bind to a single metallic central atom, forming a chelate.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
tetracarboxylic acidAn oxoacid containing four carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (8.51)18.7374
1990's15 (31.91)18.2507
2000's23 (48.94)29.6817
2010's5 (10.64)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.01 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (97.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]